microdosing with semaglutide Semaglutide: The Gentle GLP-1 Option Our Clinic’s Microdosing Semaglutide Chart:

In propensity-matched analyses, semaglutide treatment was associated with lower rates of several cardiovascular outcomes than treatment with metformin, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodium-glucose cotransporter 2 (SGLT2) inhibitors

It is a GLP-1 receptor agonist, which means it helps control blood sugar levels by stimulating the release of insulin and reducing appetite

For anyone dependent on coverage to make GLP-1s affordable, the monthly out-of-pocket cost can sting

Exercise: Physical activity improves insulin sensitivity and GLP-1 response

Our providers are available between appointments for questions and concerns